CRISPR–Casenzymeshaveenabledustomanipulatethegeneticcodewithunparalleledprecisionandefficiency.HereIexplorethestructuralandbiochemicalintricaciesthatgovernthefunctionalityofCRISPR–Castechnologies,emphasizingtheneedforanuancedmechanisticunderstandingtoovercomecurrentlimitationsandpavethewayforsaferandmoreeffectivegenome-editingapplicationsinmedicineandresearch.CRISPR–Casenzymeshaveemergedasamolecularscalpelforscientistsandphysicians,whoarenowabletotargetandmanipulateourgeneticcodeefficientlyandprecisely.
CRISPR-Cas酶使我们能够以无与伦比的精度和效率操纵遗传密码。在这里,我探讨了控制CRISPR-Cas技术功能的结构和生化复杂性,强调需要有细微的机制理解,以克服当前的局限性,并为医学和研究中更安全,更有效的基因组编辑应用铺平道路。CRISPR-Cas酶已成为科学家和医生的分子手术刀,他们现在能够高效准确地靶向和操纵我们的遗传密码。
Overthepasttenyears,scientistshaveleveragedtheabilityoftheseenzymestotargetspecificgenomicregions,beginningwithcytosineandadeninebaseeditors,andfollowedbyprimeandclickeditingtechnologies1thatexpandededitingtotransversionmutations,insertionsanddeletions.CRISPR-basedtechnologieshavemadedetectingandtreatingdisease,drugandgeneticscreening,andcreatinggeneticallymodifiedcropsmoreaccessiblethaneverbefore..
在过去的十年中,科学家利用这些酶靶向特定基因组区域的能力,从胞嘧啶和腺嘌呤碱基编辑器开始,然后是prime和click编辑技术1,该技术将编辑扩展到颠换突变,插入和缺失。基于CRISPR的技术使检测和治疗疾病,药物和基因筛选以及创造转基因作物比以往任何时候都更容易获得。。
Thisisapreviewofsubscriptioncontent,accessviayourinstitution
这是订阅内容的预览,可通过您的机构访问
Accessoptions
访问选项
Changeinstitution
变革机构
AccessNatureand54otherNaturePortfoliojournalsGetNature+,ourbest-valueonline-accesssubscription24,99€ /30dayscancelanytimeLearnmoreSubscriptioninfoforChinesecustomersWehaveadedicatedwebsiteforourChinesecustomers.Pleasegotonaturechina.comtosubscribetothisjournal.Gotonaturechina.comBuythisarticlePurchaseonSpringerLinkInstantaccesstofullarticlePDFBuynowPricesmaybesubjecttolocaltaxeswhicharecalculatedduringcheckout.
Additionalaccessoptions:
其他访问选项:
Login
Learnaboutinstitutionalsubscriptions
了解机构订阅
ReadourFAQs
阅读我们的常见问题
Contactcustomersupport
联系客户支持
CAS
中科院
PubMed
PubMedCentral
公共医学中心
GoogleScholar
谷歌学者
Guo,L.Y.etal.Nat.CellBiol.24,590–600(2022).Article
Anzalone,A.V.etal.Nature576,149–157(2019).Article
Fiumara,M.etal.Genotoxiceffectsofbaseandprimeeditinginhumanhematopoieticstemcells.Nat.Biotechnol.42,877–891(2023).Article
Chen,L.etal.Nat.Commun.12,1384(2021).Article
Berríos,K.N.etal.NucleicAcidsRes.52,2078–2090(2024).Article
DownloadreferencesAcknowledgementsThisworkhasbeenfundedbytheVagelosScholarsProgramintheMolecularLifeSciencesgrantattheUniversityofPennsylvania,theFrancesVelayFellowshipbythePanaphilandUphillFoundationsandtheNIGMSR01-GM138908granttoR.M.KohliatthePerelmanSchoolofMedicine.
下载参考文献致谢这项工作得到了宾夕法尼亚大学分子生命科学基金会Vagelos学者计划的资助,Panaphil和Uphill基金会的FrancesVelay奖学金以及佩雷尔曼医学院R.M.Kohli的NIGMSR01-GM138908资助。
TheauthorthanksR.M.KohliforhismentorshipandKohlilaboratorymembersfortheirsupportandmotivation.AuthorinformationAuthorsandAffiliationsDepartmentofMedicine,PerelmanSchoolofMedicine,UniversityofPennsylvania,Philadelphia,PA,USAJasleenGillAuthorsJasleenGillViewauthorpublicationsYoucanalsosearchforthisauthorin.
作者感谢R.M.Kohli的指导,感谢Kohli实验室成员的支持和动力。作者信息作者和附属机构美国宾夕法尼亚州费城宾夕法尼亚大学佩雷尔曼医学院医学系JasleenGillAuthorsJasleenGillView作者出版物您也可以在中搜索这位作者。
PubMedGoogleScholarCorrespondingauthorCorrespondenceto
PubMed谷歌学者通讯社
JasleenGill.Ethicsdeclarations
贾斯琳·吉尔。道德宣言
Competinginterests
相互竞争的利益
Theauthordeclaresnocompetinginterests.
Peerreview
同行评审
Peerreviewinformation
同行评审信息
NatureStructural&MolecularBiologythanksTian-MinFufortheircontributiontothepeerreviewofthiswork.
NatureStructural&MolecularBiology感谢田敏夫为这项工作的同行评审做出的贡献。
RightsandpermissionsReprintsandpermissionsAboutthisarticleCitethisarticleGill,J.DissectingthemechanismofCRISPR–Castechnologiestodesignefficientbiotechnologies.
权利和许可本文引用本文Gill,J。剖析CRISPR-Cas技术设计高效生物技术的机制。
ProvidedbytheSpringerNatureSharedItcontent-sharinginitiative